Chronic kidney disease trials in Argentina

In Argentina 11 Also abroad 798

11 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Buenos Aires, CABA, Ciudad Autónoma de Bs. As., Ciudad de Buenos Aires, Córdoba, Lanus, Lanús Este, La Plata, Mar del Plata, Rosario, San Nicolás, Santa Fe, Santiago del Estero, Temperley
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Bahía Blanca, Buenos Aires, C.a.b.a., CABA, Córdoba, Corrientes, Esperanza, Godoy Cruz, Granadero Baigorria, Junín, Lanus, Mar del Plata, Mendoza, Quilmes, Ramos Mejía, Río Cuarto, Rosario, S3000epv, San Isidro, San Martin, SAN M. de Tucuman, San Miguel de Tucumán, San Nicolás, Santa Fe, Santa Rosa, Venado Tuerto, Zárate
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Buenos Aires
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 3Taking people
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Where
CABA, Córdoba, Santa Fe
Age
18 years to 100 years
People
540 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Buenos Aires, San Luis, Santa Fe
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
CABA, Capital Federal, Ciudad de Buenos Aires, Lanús Este, La Plata, Mar del Plata, Rosario, San Nicolás, Santa Fe
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Banfield, Buenos Aires, Ciudad Autonoma, Ciudad de Buenos Aires, Ciudad Evita, Córdoba, Formosa, Hurlingham, Mar del Plata, Morón, Rosario, San Fernando, San Miguel de Tucumán, Santa Fe
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Córdoba, La Plata, Mar del Plata, Rosario, San Nicolás, Santa Rosa
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
City of Buenos Aires, Corrientes, Lanús Este, Mar del Plata
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
Phase 3Taking people
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Where
Belen de Escobar, Cuidad Autonoma de Buenos Aires, San Miguel de Tucumán
Age
0 years to 18 years
People
56 worldwide
Run by
Amgen
See details and how to joinNCT03633708
Phase 2Taking people
Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
Where
Buenos Aires
Age
18 years to 70 years
People
80
Run by
Maximo Agustin Schiavone
See details and how to joinNCT06929169